-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
United States
Headquartered in Wilmington, Delaware, ISH Food Company's plant-based shrimp product,"Shrimpish," is made from ingredients such as coconut, soy protein, and konjac, and is currently sold
at some colleges, universities, and restaurants in the United States.
ISH Food Company also plans to develop products
such as plant-based salmon, cod, lobster and crab.
proteinat some colleges, universities, and restaurants in the United States.
ISH Food Company also plans to develop products
such as plant-based salmon, cod, lobster and crab.
Maarten Geraets, General Manager of Tai Wansheng's Alternative Protein Business, said: "We are delighted to have an alliance with ISH to expand our presence
in the field of alternative proteins.
As we continue to increase our focus and investment in sustainable seafood alternatives, our Corporate Risk group has been working closely
with start-ups in the innovative alternative protein space.
”
in the field of alternative proteins.
As we continue to increase our focus and investment in sustainable seafood alternatives, our Corporate Risk group has been working closely
with start-ups in the innovative alternative protein space.
”
Earlier, Geraets told UCN that In recent years, Tai Wansheng has increased its investment in the alternative protein business and set a sales target
of $30 million for 2025.
He expects global retail sales in the alternative protein segment to be between $30 million and $50 million in 2020, and Taiwansheng plans to seize this market opportunity and contribute to
the development of the integration industry.
of $30 million for 2025.
He expects global retail sales in the alternative protein segment to be between $30 million and $50 million in 2020, and Taiwansheng plans to seize this market opportunity and contribute to
the development of the integration industry.
